Columbia Care is a specialty pharmaceutical company. It cultivates, manufactures, and provides medical and adult use cannabis products and related services. The company was founded in 2012 and is headquartered in New York.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Columbia Care news
16.05.2022
Columbia Care's GAAP loss for 3 months of 2022 was $27.906 million, down 4.4% from $29.193 million in the prior year. Revenue increased 43% to $123.087 million from $86.095 million a year earlier.
Source: 
ir.col-care.com
ir.col-care.com
24.03.2022
Columbia Care's GAAP loss for 2021 was $146.853 million, up 22.7% from $119.649 million in the previous year. Revenue increased 2.56 times to $460.08 million from $179.503 million a year earlier.
Source: ir.col-care.com
ir.col-care.com
23.03.2022
Columbia Care has entered into a merger agreement with Cresco Labs. Columbia shareholders will receive 0.5579 shares of Cresco for each of their securities and will own 35% of the combined company. The deal is scheduled to close in Q4 2022.
Source: ir.col-care.com
ir.col-care.com
15.11.2021
Columbia Care's IFRS loss for 9M 2021 was $63.387 million, up 6.5% from $59.521 million in the prior year. Revenue increased 3.1 times to $320.804 million from $103.439 million a year earlier.
Source: ir.col-care.com
ir.col-care.com
General information
| Company name | Columbia Care |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 680 Fifth Avenue 24th Floor New York, NY 10019 United States |
| Mailing address | 680 Fifth Avenue 24th Floor New York, NY 10019 United States |
| Website | ir.col-care.com |
English (US) 